• Product
  • Our Science
    • Pipeline
    • Focus Areas
    • Research and Medical Grants
  • Patients
    • Patient Resources
  • Investors
    • Stock Information
    • News & SEC Filings
    • Financial Results
    • Shareholder Information
    • Analyst Coverage

    EVENTS, PRESENTATIONS & PUBLICATIONS

    • Past Events
    • Upcoming Events
    • Presentations
    • Publications
  • Company
    • Our Strategy
    • Company Leadership
    • Careers
    • Corporate Governance
    • Compliance and Transparency
  • News & Resources
    • News
Contact Us
  • Product
    • Pipeline
    • Focus Areas
    • Research and Medical Grants

    Pipeline

    Development Programs

    Building a broad portfolio of respiratory therapeutics

    Learn More
    Our Science
    • Patient Resources

    Patient Resources

    Educational materials

    Helping to understand and improve respiratory care

    Learn More
    Patients
  • May 2025

    Company Presentation

    Developing innovative therapies for the treatment of respiratory diseases

    Download Now

    • Stock Information
    • News & SEC Filings
    • Financial Results
    • Shareholder Information
    • Analyst Coverage

    EVENTS, PRESENTATIONS & PUBLICATIONS

    • Past Events
    • Upcoming Events
    • Presentations
    • Publications
    Investors
  • We aim to improve health and wellbeing for those affected by chronic respiratory diseases.

    David Zaccardelli

    President and CEO

    • Our Strategy
    • Company Leadership
    • Careers
    • Corporate Governance
    • Compliance and Transparency
    Company
  • Latest News

    Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

    Read More

    • News
    News & Resources
  • Contact Us

Author: wpcomvip

Hello world!

Posted on February 29, 2024 by wpcomvip

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Posted in Uncategorized1 Comment on Hello world!

Recent Posts

  • Hello world!

Recent Comments

  1. A WordPress Commenter on Hello world!

Archives

  • February 2024

Categories

  • Uncategorized
Follow Us

© 2025 Verona Pharma plc. All rights reserved. Verona Pharma, Ohtuvayre, and the associated logos are registered trademarks of Verona Pharma plc.

  • Website Terms & Conditions
  • Email Alerts
  • Legal Information
  • Cookies
  • Privacy Notice
Verify Approval for www.veronapharma.com
Get Started
  • Product
  • Our Science
  • Patients
  • Investors
  • Company
  • News & Resources
Investors
  • Stock Information
  • News & SEC Filings
  • Events & Presentations
  • Financial Results
  • Shareholder Information
  • Analyst Coverage
Follow Us

MERCK & CO., INC., Rahway, NJ, USA

(known as MSD outside the United States and Canada)

Effective October 7th, 2025, Verona Pharma Plc and it subsidiaries1 are subsidiaries of Merck & Co., Inc. (Rahway, New Jersey USA)

Click For Announcement
Click to Visit MSD

1 Subsidiaries include Verona Pharma, Inc. (US) and Verona Pharma Ireland Limited (Ireland).

Contact us

Verona Medical Information

For product-related questions, please contact us at
1-888-672-0371

Monday – Friday 8:30 AM – 5:00 PM ET

Adverse Event and/or Product Compliant Reporting

To report suspected adverse reactions, contact Verona Pharma, Inc, at
1-888-672-0371

Monday – Friday 8:30 AM – 5:00 PM ET